Find the latest pharmaceutical market place for formulations enquiry about Solifenacin Succinate on PharmaCompass.com.

Various Finished Dosage Formulations needed in China [ENA14285]

A company that focuses in development, manufacturing and distribution of various pharmaceutical products is looking for suppliers of Various Finished Dosage Formulations for commercial purpose. The suppliers must support this enquiry with EU CTD dossier.
1. Ciprofloxacin (500 mg/ 850 mg/ 1000 mg) Tablets
2. Clarithromycin (250 mg & 500 mg) Tablets
3. Azithromycin (250 mg & 500 mg) Tablets
4. Moxifloxacin (400 mg) Tablets
5. Solifenacin (5 mg & 10 mg) Tablets

Reply

08 Jul 2022

Various Finished Dosage Formulations needed in Vietnam [ENA12831]

A company that deals in the distribution of a wide range of products in allopathic formulations, herbal formulations, nutraceuticals, vaccines and orthopedic implants is looking for suppliers of Various Finished Dosage Formulations for commercial purpose. The required quantity is 500,000 units for each.
1. Saxagliptin (2.5 mg & 5 mg) + Metformin (1000 mg & 500 mg) Tablets
2. Sitagliptin (50 mg & 100 mg) + Metformin (500 mg, 850 mg & 1000 mg) Tablets
3. Solifenacin Succinate (5 mg & 10 mg) Tablets
4. Sorafenib (200 mg) Tablets
5. Sunitinib (12.5 mg, 25 mg & 50 mg) Capsules

Reply

26 Feb 2022

Various Finished Dosage Formulations needed in Bahrain [ENA10592]

A company that specializes in the trading of pharmaceuticals, medical supplies and nutrition is looking for suppliers of Various Finished Dosage Formulations for tender purposes.
1. Propranolol HCl (10 mg) Tablets. The required quantity is 100,000 units.
2. Solifenacin (5 mg & 10 mg) Tablets. The required quantity is 84,000 units & 14,100 units respectively.
3. Tretinoin (0.05%) Cream. The required quantity is 600 units.
4. Cyanocobalamin (1000 mcg) Injections. The required quantity is 1500 units.
5. Salbutamol (5 mg/ ml in 20 ml) Respirator. The required quantity is 2000 units.
6. Sodium Benzoate (2 g in 10 ml) Injections. The required quantity is 50 units.
7. Drospirenone (3 mg) + Ethinyl Estradiol (0.03 mg) Tablets. The required quantity is 14,280 units.
8. Labetalol Hydrochloride (5 mg/ ml in 20 ml) Injections. The required quantity is 600 units.
9. Noradrenaline (1 mg/ml in 4 ml). The required quantity is 20,000 Ampoules.
10. Hydroxychloroquine Sulfate (200 mg) Tablets. The required quantity is 84,000 units.
11. Lacosamide (10 mg/ ml) Oral Syrup. The required quantity is 50 units.

Reply

08 Jun 2021

Various Finished Dosage Formulations required with CTD Dossiers needed in Ukraine [ENA07186]

A pharmaceutical manufacturing company that deals in portfolios like antibiotics, antitussive, painkillers, anti-anemic & many more is looking for suppliers of Various Finished Dosage Formulations. The end market are CIS countries (Kazakhistan, Azerbaijan, Uzbekistan & Ukraine). The suppliers must support this enquiry with CPP.
1. Ademetionine 400 mg Tablet (10,000 units in 20 pack size)
2. Candesartan + Amlodipine + HCTZ (16 mg + 5 mg + 12.5 mg and 16 mg + 10 mg + 12.5 mg) Tablet (20,000 units in 28 pack size for each)
3. Finasteride 5 mg + Tadalafil 5 mg Tablet (10,000 units in 28 pack size)
4. Olmesartan + Amlodipine + HCTZ (20 mg + 5 mg + 12.5 mg and 40 mg + 5 mg + 12.5 mg) Tablet (20,000 units in 28 pack size for each)
5. Solifenacin 6 mg + Tamsolusin 0.4 mg Tablet (20,000 units in 30 pack size)
6. Rivaroxaban 2.5 mg, 10 mg, 15, mg, 20 mg Tablet

Reply

29 Apr 2020

Solifenacin tablets (dossier + supply) needed in Europe [ENA03114]

A pharmacovigilance and regulatory consulting company based in the UK and offices in Netherlands and United States is looking for European manufacturers of Solifenacin tablets (dossier + supply).

Reply

11 Jan 2019

Privacy policy
Terms and conditions
Disclaimers
Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.